In the present study, we investigated whether TSA-mediated HIF-1α acetylation affects tumor cell survival via nuclear translocation and binding to the HRE of the VEGF promoter using HeLa cells for the continuation of our previous study [10, 27, 44]. The gene discussed is HIF1A; the disease is neoplasm.